Nigeria has received 3.94 million doses of the Oxford-AstraZeneca COVID-19 vaccine through the COVID-19 Vaccines Global Assess Facility, COVAX.
This makes Nigeria the third Africa country to benefit from the COVAX facility after Ghana and Ivory Coast.
COVAX, an initiative co-led by the vaccine alliance, GAVI and the World Health Organisation (WHO) aims to ensure equitable access to COVID-19 vaccines by dividing about two billion doses across 92 low and middle-income countries.
The facility promises access to vaccines for up to 20 per cent of participating countries’ population with an initial supply beginning in the first quarter of the year to immunise three per cent of their populations.
The COVID-19 vaccines arrived at the Nnamdi Azikiwe International airport at about 11:45 a.m. on Tuesday.
Support PREMIUM TIMES' journalism of integrity and credibility
Good journalism costs a lot of money. Yet only good journalism can ensure the possibility of a good society, an accountable democracy, and a transparent government.
For continued free access to the best investigative journalism in the country we ask you to consider making a modest support to this noble endeavour.
By contributing to PREMIUM TIMES, you are helping to sustain a journalism of relevance and ensuring it remains free and available to all.
TEXT AD: To advertise here . Call Willie +2347088095401...